Novartis India Ltd.

NSE: NOVARTIND | BSE: 500672 | ISIN: INE234A01025 | Industry: Pharmaceuticals
| Mid-range Performer
918.1500 -2.65 (-0.29%)
BSE Sep 11, 2025 16:01 PM
Volume: 1,521
 

logo
Novartis India Ltd.
17 Feb 2024
918.15
-0.29%
Novartis Starts 'Strategic Review' Of India Listed Business Amid Reports Of Sale Talks
Novartis Starts 'Strategic Review' Of India Listed Business Amid Reports Of Sale Talks
NDTV Profit
Media reports suggest that drugmaker Dr. Reddy's Laboratories Ltd. is in the race to acquire the Novartis AG's stake in Novartis India.
Novartis India Ltd. is trading below all available SMAs
Dr. Reddy's eyeing to acquire Novartis' India arm: Report
Moneycontrol | 17 Feb 2024 3 more
More from Novartis India Ltd.
Recommended
Market closes higher, Tega Industries to buy Molycop with Apollo Funds in a $1.5 bn deal
Trendlyne Marketwatch | 11 Sep 2025, 04:07PM
India’s IPO story in 2025: Investors go selective, backing quality over hype
The Baseline | 11 Sep 2025, 03:50PM
Divested business and price controls cut Novartis revenue and profits
| 03 Feb 2017